Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer

Peer Review reports

Original Submission
11 Feb 2012	Submitted	Original manuscript
19 Apr 2012	Reviewed	Reviewer Report - Motoki Miyazawa
31 May 2012	Reviewed	Reviewer Report - Alfredo Carrato
Resubmission - Version 2
	Submitted	Manuscript version 2
12 Jul 2012	Author responded	Author comments - Friedrich Hubertus Schmitz-Winnenthal
Resubmission - Version 3
12 Jul 2012	Submitted	Manuscript version 3
Publishing
17 Jul 2012	Editorially accepted
20 Aug 2012	Article published	10.1186/1471-2407-12-361

Back to article page